Henan Taloph Pharmaceutical Stock Co Ltd (600222) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.014x

Based on the latest financial reports, Henan Taloph Pharmaceutical Stock Co Ltd (600222) has a cash flow conversion efficiency ratio of 0.014x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥22.69 Million ≈ $3.32 Million USD) by net assets (CN¥1.65 Billion ≈ $241.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 600222 market cap for the company's overall valuation and market capitalisation.

Henan Taloph Pharmaceutical Stock Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Henan Taloph Pharmaceutical Stock Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Henan Taloph Pharmaceutical Stock Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Henan Taloph Pharmaceutical Stock Co Ltd ranked by their cash flow conversion efficiency. Explore Henan Taloph Pharmaceutical Stock Co Ltd (600222) cash flow quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Helen of Troy Ltd NASDAQ:HELE	-0.001x
Khang Dien House Trading and Investment JSC VN:KDH	-0.029x
Midland States Bancorp, Inc. NASDAQ:MSBI	0.052x
Sercomm Corp TW:5388	-0.202x
Zhejiang Aokang Shoes Co Ltd SHG:603001	0.002x
Guangdong Insight Brand Marketing Group Co Ltd SHE:300781	0.006x
Turkiye Sinai Kalkinma Bankasi AS IS:TSKB	0.071x
Hainan Expressway Co Ltd SHE:000886	-0.027x

Annual Cash Flow Conversion Efficiency for Henan Taloph Pharmaceutical Stock Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Henan Taloph Pharmaceutical Stock Co Ltd from 1998 to 2025. View Henan Taloph Pharmaceutical Stock Co Ltd stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.66 Billion ≈ $243.28 Million	CN¥47.16 Million ≈ $6.90 Million	0.028x	+216.53%
2024-12-31	CN¥1.63 Billion ≈ $237.97 Million	CN¥-39.59 Million ≈ $-5.79 Million	-0.024x	-190.35%
2023-12-31	CN¥1.62 Billion ≈ $237.55 Million	CN¥43.74 Million ≈ $6.40 Million	0.027x	+134.96%
2022-12-31	CN¥1.61 Billion ≈ $236.19 Million	CN¥-124.41 Million ≈ $-18.20 Million	-0.077x	-237.49%
2021-12-31	CN¥1.78 Billion ≈ $260.12 Million	CN¥99.66 Million ≈ $14.58 Million	0.056x	+16.86%
2020-12-31	CN¥1.53 Billion ≈ $223.97 Million	CN¥73.43 Million ≈ $10.74 Million	0.048x	+51.55%
2019-12-31	CN¥1.31 Billion ≈ $191.96 Million	CN¥41.53 Million ≈ $6.08 Million	0.032x	-63.14%
2018-12-31	CN¥1.39 Billion ≈ $203.58 Million	CN¥119.47 Million ≈ $17.48 Million	0.086x	+459.02%
2017-12-31	CN¥1.51 Billion ≈ $220.70 Million	CN¥23.17 Million ≈ $3.39 Million	0.015x	-67.36%
2016-12-31	CN¥1.50 Billion ≈ $219.49 Million	CN¥70.60 Million ≈ $10.33 Million	0.047x	+43.24%
2015-12-31	CN¥1.50 Billion ≈ $219.41 Million	CN¥49.27 Million ≈ $7.21 Million	0.033x	-56.47%
2014-12-31	CN¥1.19 Billion ≈ $173.57 Million	CN¥89.54 Million ≈ $13.10 Million	0.075x	+1340.44%
2013-12-31	CN¥1.09 Billion ≈ $159.85 Million	CN¥-6.65 Million ≈ $-972.81K	-0.006x	-104.57%
2012-12-31	CN¥656.50 Million ≈ $96.07 Million	CN¥87.45 Million ≈ $12.80 Million	0.133x	+79526.32%
2011-12-31	CN¥628.89 Million ≈ $92.03 Million	CN¥105.20K ≈ $15.39K	0.000x	+100.51%
2010-12-31	CN¥609.32 Million ≈ $89.16 Million	CN¥-20.00 Million ≈ $-2.93 Million	-0.033x	-189.72%
2009-12-31	CN¥586.04 Million ≈ $85.76 Million	CN¥21.45 Million ≈ $3.14 Million	0.037x	+12.00%
2008-12-31	CN¥554.97 Million ≈ $81.21 Million	CN¥18.13 Million ≈ $2.65 Million	0.033x	-20.12%
2007-12-31	CN¥521.57 Million ≈ $76.32 Million	CN¥21.34 Million ≈ $3.12 Million	0.041x	+1149.87%
2006-12-31	CN¥487.05 Million ≈ $71.27 Million	CN¥1.59 Million ≈ $233.25K	0.003x	+459.04%
2005-12-31	CN¥471.96 Million ≈ $69.06 Million	CN¥276.30K ≈ $40.43K	0.001x	-98.54%
2004-12-31	CN¥455.68 Million ≈ $66.68 Million	CN¥18.25 Million ≈ $2.67 Million	0.040x	+371.94%
2003-12-31	CN¥440.61 Million ≈ $64.48 Million	CN¥3.74 Million ≈ $547.22K	0.008x	-51.32%
2002-12-31	CN¥428.30 Million ≈ $62.67 Million	CN¥7.47 Million ≈ $1.09 Million	0.017x	-86.79%
2001-12-31	CN¥416.84 Million ≈ $61.00 Million	CN¥55.03 Million ≈ $8.05 Million	0.132x	+6089.51%
2000-12-31	CN¥410.41 Million ≈ $60.06 Million	CN¥875.36K ≈ $128.09K	0.002x	-99.14%
1999-12-31	CN¥401.57 Million ≈ $58.76 Million	CN¥99.32 Million ≈ $14.53 Million	0.247x	+36.58%
1998-12-31	CN¥154.84 Million ≈ $22.66 Million	CN¥28.04 Million ≈ $4.10 Million	0.181x	--

About Henan Taloph Pharmaceutical Stock Co Ltd

SHG:600222 China Drug Manufacturers - Specialty & Generic

Market Cap

$681.90 Million

CN¥4.66 Billion CNY

Market Cap Rank

#10868 Global

#3018 in China

Share Price

CN¥8.12

Change (1 day)

+2.78%

52-Week Range

CN¥6.26 - CN¥8.95

All Time High

CN¥10.35